Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia

Riferimento: 
Med Oncol. 2012 Mar;29(1):260-2. doi: 10.1007/s12032-011-9834-y. Epub 2011 Feb 5.
Autori: 
Colovic N, Tomin D, Vidovic A, Tosic N, Atkinson HD, Colovic MD.
Fonte: 
Institute of Hematology, Clinical Center for Serbia, Koste Todorovića 2, 11000 Belgrade, Serbia. natasacolovic73@gmail.com
Anno: 
2012
Azione: 
Un caso ad alto rischio di leucemia acuta promielocitica (APL) diagnosticato per la presenza di anticorpi dell'acido retinoico alfa (RARα) nel fluido cerebrospinale (CSF).
Target: 
RARα – CSF/leucemia acuta promielocitica.

ABSTRACT
Central nervous system (CNS) involvement in acute promyelocytic leukemia (APL) is rare and tends to be seen mostly following treatment with all-trans retinoic acid (ATRA), due to prolonged patient survival and poor penetration of the drug in the CNS. At least 10% of extramedullary relapses in APL involve the CNS, and associated factors include an increased age, the BCR isoform, the development of differentiation syndrome, a high white cell count at presentation and hemorrhage into the CNS during induction therapy. We present the case of a patient with high-risk APL, CD56+, CD2+ in whom a CNS relapse was diagnosed through the presence of a PML/RARα rearrangement on PCR of the cerebrospinal fluid (CSF).

Sostanze: